Gilbert H. Kliman, a director at Glaukos Corp (NYSE:GKOS), recently executed a series of stock transactions, as disclosed in a filing with the Securities and Exchange Commission. The transactions come as the company’s stock trades near its 52-week high of $147.65, having delivered an impressive 74.78% return year-to-date according to InvestingPro data. On December 11, Kliman sold 2,000 shares of Glaukos’ common stock at an average price of $144.01 per share, totaling approximately $288,020. This sale was part of multiple trades executed at prices ranging from $144.00 to $144.05.
In addition to the sale, Kliman exercised stock options to acquire 2,000 shares at a price of $32.00 per share, which he then sold. Following these transactions, Kliman holds 32,336 shares of Glaukos common stock directly, including 2,611 restricted stock units that have yet to vest.
In other recent news, Glaukos Corporation has been the focus of several analyst upgrades and adjustments. Citi upgraded Glaukos stock to Buy from Neutral, citing a positive outlook on the company’s iDose product, which has seen its revenue double in the third quarter of 2024 to approximately $8 million. UBS also rated Glaukos stock as Buy, driven by the anticipated success of the iDose product and continued stent franchise growth. On the other hand, Stifel increased its price target for Glaukos shares to $153.00, maintaining a Buy rating, driven by optimism for iDose sales.
In addition to analyst upgrades, Glaukos has also secured approximately $53.2 million from unwinding a portion of its capped call transactions. This significant financial move is part of the company’s financial strategies surrounding its convertible senior notes. Furthermore, Glaukos has entered into agreements to partially unwind specific capped call transactions related to its convertible senior notes, a strategic move in managing its financial instruments.
These recent developments reflect the company’s ongoing efforts to enhance its financial position and market value. As analysts continue to monitor the company’s performance and potential, investors will likely pay close attention to the company’s future moves.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
